Tighten up value for money appraisals of new drugs in England, urges DTB
The body that appraises the clinical and cost effectiveness of new drugs in England would do well to take a leaf out of its sister organisations' books in Wales and Scotland, says an editorial in the Drug and Therapeutics ...
Dec 14, 2013
0
0